Lung cancer immunotherapy: progress, pitfalls, and promises

🤖 Plain-English Summary

Lung cancer is the primary cause of mortality in the United States and around the globe. Additionally, the review also explores the implication of nanomedicine in lung cancer immunotherapy as well as the combinatorial application of traditional therapy along with immunotherapy regimens.

🔑 Key Findings

• Therapeutic options for lung cancer treatment include surgery, radiation therapy, chemotherapy, and targeted drug therapy.
• Medical management is often associated with the development of treatment resistance leading to relapse.
• Immunotherapy is profoundly altering the approach to cancer treatment owing to its tolerable safety profile, sustained therapeutic response due to immunological memory generation, and effectiveness across a broad patient population.

🔗 Related Resources